Danielle Antalffy
Stock Analyst at UBS
(3.64)
# 824
Out of 5,116 analysts
197
Total ratings
50%
Success rate
7.07%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $88 → $86 | $87.07 | -1.23% | 7 | Jan 28, 2026 | |
| EW Edwards Lifesciences | Maintains: Neutral | $92 → $95 | $81.36 | +16.77% | 14 | Jan 12, 2026 | |
| SGHT Sight Sciences | Maintains: Buy | $7 → $12 | $6.28 | +91.08% | 3 | Dec 23, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $89 → $91 | $75.78 | +20.08% | 8 | Dec 23, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $145 | $119.38 | +21.46% | 3 | Dec 23, 2025 | |
| PRCT PROCEPT BioRobotics | Initiates: Buy | $62 | $28.96 | +114.09% | 4 | Dec 12, 2025 | |
| MDT Medtronic | Maintains: Neutral | $95 → $102 | $102.96 | -0.93% | 12 | Nov 19, 2025 | |
| PODD Insulet | Upgrades: Buy | $355 → $400 | $255.81 | +56.37% | 13 | Nov 19, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $6.5 → $5.85 | $2.32 | +152.16% | 8 | Nov 7, 2025 | |
| INMD InMode | Maintains: Neutral | $16 → $16 | $15.71 | +1.85% | 5 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $106 → $95 | $73.04 | +30.07% | 10 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $24 → $21 | $20.07 | +4.63% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $585 → $600 | $504.22 | +19.00% | 3 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $140 | $93.53 | +49.68% | 14 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $214 | $227.25 | -5.83% | 6 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $8 | $8.69 | -7.94% | 4 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $57 | $22.04 | +158.62% | 2 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $19.89 | -14.53% | 15 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $36.94 | +57.03% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $109.30 | +35.41% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $369.56 | +0.12% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $3.96 | -43.18% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $5.01 | +16,367.07% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $34.85 | -59.83% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $66.92 | +49.43% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $15.13 | -20.69% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $35.98 | +25.07% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $203.48 | +35.15% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.00 | +400.00% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $5.90 | +611.86% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $7.33 | +718.55% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.63 | +2,280.95% | 1 | Sep 1, 2020 |
Zimmer Biomet Holdings
Jan 28, 2026
Maintains: Sell
Price Target: $88 → $86
Current: $87.07
Upside: -1.23%
Edwards Lifesciences
Jan 12, 2026
Maintains: Neutral
Price Target: $92 → $95
Current: $81.36
Upside: +16.77%
Sight Sciences
Dec 23, 2025
Maintains: Buy
Price Target: $7 → $12
Current: $6.28
Upside: +91.08%
Inspire Medical Systems
Dec 23, 2025
Maintains: Neutral
Price Target: $89 → $91
Current: $75.78
Upside: +20.08%
Glaukos
Dec 23, 2025
Maintains: Buy
Price Target: $140 → $145
Current: $119.38
Upside: +21.46%
PROCEPT BioRobotics
Dec 12, 2025
Initiates: Buy
Price Target: $62
Current: $28.96
Upside: +114.09%
Medtronic
Nov 19, 2025
Maintains: Neutral
Price Target: $95 → $102
Current: $102.96
Upside: -0.93%
Insulet
Nov 19, 2025
Upgrades: Buy
Price Target: $355 → $400
Current: $255.81
Upside: +56.37%
Treace Medical Concepts
Nov 7, 2025
Maintains: Neutral
Price Target: $6.5 → $5.85
Current: $2.32
Upside: +152.16%
InMode
Nov 6, 2025
Maintains: Neutral
Price Target: $16 → $16
Current: $15.71
Upside: +1.85%
Nov 3, 2025
Maintains: Buy
Price Target: $106 → $95
Current: $73.04
Upside: +30.07%
Oct 31, 2025
Maintains: Neutral
Price Target: $24 → $21
Current: $20.07
Upside: +4.63%
Oct 23, 2025
Maintains: Neutral
Price Target: $585 → $600
Current: $504.22
Upside: +19.00%
Oct 23, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $93.53
Upside: +49.68%
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $227.25
Upside: -5.83%
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $8.69
Upside: -7.94%
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $22.04
Upside: +158.62%
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $19.89
Upside: -14.53%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $36.94
Upside: +57.03%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $109.30
Upside: +35.41%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $369.56
Upside: +0.12%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $3.96
Upside: -43.18%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $5.01
Upside: +16,367.07%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $34.85
Upside: -59.83%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $66.92
Upside: +49.43%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $15.13
Upside: -20.69%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $35.98
Upside: +25.07%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $203.48
Upside: +35.15%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.00
Upside: +400.00%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $5.90
Upside: +611.86%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $7.33
Upside: +718.55%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.63
Upside: +2,280.95%